|
Synonyms: compound of formula (I) [1] | UCB-6492
Compound class:
Synthetic organic
Comment: UCB6492 is an orally bioavailable small-molecule IL-17A inhibitor [1]. The structure was first disclosed during the European Federation for Medicinal Chemistry and Chemical Biology's International Symposium on Medicinal Chemistry (EFMC-ISMC) in 2026. The compound is proposed for the treatment of IL-17A-mediated inflammatory and autoimmune disorders.
|
|
|||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| N-[(S)-(4,4-difluorocyclohexyl)-[3-[1-(2,2-difluoropropylcarbamoyl)-3-hydroxy-3-methylcyclobutyl]imidazo[1,2-b][1,2,4]triazin-6-yl]methyl]-4-methyl-1,2,5-oxadiazole-3-carboxamide |
Synonyms ![]() |
|
| compound of formula (I) [1] | UCB-6492 | |
Database Links ![]() |
|
| CAS Registry No. | 3060410-85-4 |
| PubChem CID | 172375709 |
| Search Google for chemical match using the InChIKey | KEJKJRWTDWOPSD-JKFKMHIGSA-N |
| Search Google for chemicals with the same backbone | KEJKJRWTDWOPSD |
| UniChem Compound Search for chemical match using the InChIKey | KEJKJRWTDWOPSD-JKFKMHIGSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | KEJKJRWTDWOPSD-JKFKMHIGSA-N |